238 related articles for article (PubMed ID: 32692621)
1. Opportunities to boost naloxone awareness among people who misuse opioid analgesics who have not used illegal opioids.
Gicquelais RE; Bohnert ASB; Fernandez AC
Subst Abus; 2021; 42(3):372-376. PubMed ID: 32692621
[TBL] [Abstract][Full Text] [Related]
2. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
3. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.
Bennett AS; Scheidell J; Bowles JM; Khan M; Roth A; Hoff L; Marini C; Elliott L
Harm Reduct J; 2022 Mar; 19(1):20. PubMed ID: 35246165
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey.
Cooper-Ohm S; Habecker P; Humeniuk R; Bevins RA
Harm Reduct J; 2024 Feb; 21(1):37. PubMed ID: 38336722
[TBL] [Abstract][Full Text] [Related]
5. Naloxone Knowledge and Attitudes Towards Overdose Response Among Family Members of People who Misuse Opioids.
Resko SM; Pasman E; Hicks DL; Lee G; Ellis JD; O'Shay S; Brown S; Agius E
J Community Health; 2024 Feb; 49(1):70-77. PubMed ID: 37450091
[TBL] [Abstract][Full Text] [Related]
6. Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.
Tse WC; Djordjevic F; Borja V; Picco L; Lam T; Olsen A; Larney S; Dietze P; Nielsen S
Int J Drug Policy; 2022 Feb; 100():103513. PubMed ID: 34798434
[TBL] [Abstract][Full Text] [Related]
7. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
8. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
[TBL] [Abstract][Full Text] [Related]
9. Opioid Misuse Harm Reduction.
Bailey NR; Mitchell KA; Miller TM
J Addict Nurs; 2024 Jan-Mar 01; 35(1):3-14. PubMed ID: 38373177
[TBL] [Abstract][Full Text] [Related]
10. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
[TBL] [Abstract][Full Text] [Related]
11. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
12. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
[TBL] [Abstract][Full Text] [Related]
13. On the front lines of the opioid epidemic: Rescue by naloxone.
Skolnick P
Eur J Pharmacol; 2018 Sep; 835():147-153. PubMed ID: 30092179
[TBL] [Abstract][Full Text] [Related]
14. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.
Lin LA; Brummett CM; Waljee JF; Englesbe MJ; Gunaseelan V; Bohnert ASB
J Gen Intern Med; 2020 Feb; 35(2):420-427. PubMed ID: 31820218
[TBL] [Abstract][Full Text] [Related]
15. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.
Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L
Pain Med; 2018 Mar; 19(3):533-540. PubMed ID: 28340185
[TBL] [Abstract][Full Text] [Related]
17. If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.
Slocum S; Ozga JE; Joyce R; Walley AY; Pollini RA
BMC Public Health; 2022 Apr; 22(1):735. PubMed ID: 35418048
[TBL] [Abstract][Full Text] [Related]
18. The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees.
Argenyi MS; Evans JK; Gay Y; Epstein DH; Weiss ST
Clin Toxicol (Phila); 2023 Jul; 61(7):509-517. PubMed ID: 37427894
[TBL] [Abstract][Full Text] [Related]
19. Trends in overdose experiences and prevention behaviors among people who use opioids in Baltimore, MD, 2017-2019.
Dayton L; Mazhnaya A; Schneider KE; Kong X; Winiker A; Davey-Rothwell M; Tobin KE; Latkin CA
Drug Alcohol Depend; 2021 Apr; 221():108650. PubMed ID: 33684772
[TBL] [Abstract][Full Text] [Related]
20. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users.
Frank D; Mateu-Gelabert P; Guarino H; Bennett A; Wendel T; Jessell L; Teper A
Int J Drug Policy; 2015 Jan; 26(1):84-91. PubMed ID: 25151334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
